Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.0%
5Y CAGR+37.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+11.0%/yr
Annual compound
5Y CAGR
+37.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $88.68M | +31.3% |
| 2024 | $67.53M | +5.3% |
| 2023 | $64.16M | -0.9% |
| 2022 | $64.76M | +17.2% |
| 2021 | $55.27M | +202.5% |
| 2020 | $18.27M | - |